A novel disease mechanism leading to the expression of a disallowed gene in the pancreatic beta-cell identified by non-coding, regulatory mutations controlling HK1

Matthew N. Wakeling, Nick D. L. Owens, Jessica R. Hopkinson, Matthew B. Johnson, Jayne A.L. Houghton, Antonia Dastamani, Christine S. Flaxman, Rebecca C. Wyatt, Thomas I. Hewat, Jasmin J. Hopkins, Thomas W. Laver, Rachel Van Heugten, Michael N. Weedon, Elisa De Franco, Kashyap A. Patel, Sian Ellard, Noel G. Morgan, Edmund Cheesman, Indraneel Banerjee, Andrew T. Hattersley, Mark J. Dunne, International Congenital Hyperinsulinism Consortium, Sarah J. Richardson, Sarah E. Flanagan
doi: https://doi.org/10.1101/2021.12.03.21267240

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Back to top
Posted December 05, 2021.
Download PDF

Supplementary Material

Data/Code
Email
A novel disease mechanism leading to the expression of a disallowed gene in the pancreatic beta-cell identified by non-coding, regulatory mutations controlling HK1
Matthew N. Wakeling, Nick D. L. Owens, Jessica R. Hopkinson, Matthew B. Johnson, Jayne A.L. Houghton, Antonia Dastamani, Christine S. Flaxman, Rebecca C. Wyatt, Thomas I. Hewat, Jasmin J. Hopkins, Thomas W. Laver, Rachel Van Heugten, Michael N. Weedon, Elisa De Franco, Kashyap A. Patel, Sian Ellard, Noel G. Morgan, Edmund Cheesman, Indraneel Banerjee, Andrew T. Hattersley, Mark J. Dunne, International Congenital Hyperinsulinism Consortium, Sarah J. Richardson, Sarah E. Flanagan
medRxiv 2021.12.03.21267240; doi: https://doi.org/10.1101/2021.12.03.21267240
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area